Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein
Authors:
- 10 March 2022
- journal article
- research article
- Published by Elsevier in Vascular Pharmacology
- Vol. 144, 106977
Abstract
No abstract availableKeywords
Funding Information
- Uniwersytet Jagielloński Collegium Medicum (K/ZDS/002936)
- Uniwersytet Jagielloński Collegium Medicum Wydział Lekarski
This publication has 38 references indexed in Scilit:
- Identification of Fibrin Clot-Bound Plasma ProteinsPLOS ONE, 2012
- Clot lysis time in platelet-rich plasma: Method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acidPlatelets, 2011
- Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery DiseaseMayo Clinic Proceedings, 2009
- Fibrin clot properties are altered in patients with chronic obstructive pulmonary diseaseThrombosis and Haemostasis, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptorProceedings of the National Academy of Sciences, 2008
- Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery diseaseJournal of Thrombosis and Haemostasis, 2006
- Beneficial Cardiovascular Pleiotropic Effects of StatinsCirculation, 2004
- Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosisAtherosclerosis, 2004
- Quantitative Assessment of Platelet Function and Clot Structure in Patients With Severe Coronary Artery DiseaseThe American Journal of the Medical Sciences, 1994